Big Pharma Is Paying Doctors to Prescribe Drugs for Multiple Sclerosis
Update: 2025-10-21
Description
- An analysis showed that 78.5% of neurologists received payments from pharmaceutical companies, with doctors receiving more money prescribing more multiple sclerosis (MS) drugs from those companies
- Payment amounts create dose-dependent effects. Even $50 payments slightly influenced prescribing patterns, while $5,000 payments nearly doubled likelihood of favoring specific company drugs
- Non-consulting fees like speakership appearances accounted for two-thirds of total payments, creating ongoing relationships and brand familiarity among physicians
- A combination of smart sun exposure and vitamin D3 supplementation can help manage MS. For best results, you’ll need to minimize vegetable oil intake and maintain levels between 60 and 80 ng/mL
- Optimizing gut microbiota through proper carbohydrate intake, gradual fiber increases, and minimizing processed foods also supports MS management without pharmaceutical intervention
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
